2
|
Schrumpf E, Tan C, Karlsen TH, Sponheim J, Björkström NK, Sundnes O, Alfsnes K, Kaser A, Jefferson DM, Ueno Y, Eide TJ, Haraldsen G, Zeissig S, Exley MA, Blumberg RS, Melum E. The biliary epithelium presents antigens to and activates natural killer T cells. Hepatology 2015; 62:1249-59. [PMID: 25855031 PMCID: PMC4589438 DOI: 10.1002/hep.27840] [Citation(s) in RCA: 59] [Impact Index Per Article: 6.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/13/2014] [Accepted: 04/07/2015] [Indexed: 02/02/2023]
Abstract
UNLABELLED Cholangiocytes express antigen-presenting molecules, but it has been unclear whether they can present antigens. Natural killer T (NKT) cells respond to lipid antigens presented by the major histocompatibility complex class I-like molecule CD1d and are abundant in the liver. We investigated whether cholangiocytes express CD1d and present lipid antigens to NKT cells and how CD1d expression varies in healthy and diseased bile ducts. Murine and human cholangiocyte cell lines as well as human primary cholangiocytes expressed CD1d as determined by flow cytometry and western blotting. Murine cholangiocyte cell lines were able to present both exogenous and endogenous lipid antigens to invariant and noninvariant NKT cell hybridomas and primary NKT cells in a CD1d-dependent manner. A human cholangiocyte cell line, cholangiocarcinoma cell lines, and human primary cholangiocytes also presented exogenous CD1d-restricted antigens to invariant NKT cell clones. CD1d expression was down-regulated in the biliary epithelium of patients with late primary sclerosing cholangitis, primary biliary cirrhosis, and alcoholic cirrhosis compared to healthy controls. CONCLUSIONS Cholangiocytes express CD1d and present antigens to NKT cells and CD1d expression is down-regulated in diseased biliary epithelium, findings which show that the biliary epithelium can activate an important lymphocyte subset of the liver. This is a potentially important immune pathway in the biliary system, which may be capable of regulating inflammation in the context of biliary disease.
Collapse
Affiliation(s)
- Elisabeth Schrumpf
- Norwegian PSC Research Center, Division of Cancer, Surgery and Transplantation, Oslo University Hospital, Rikshospitalet, Oslo, Norway,K.G. Jebsen Inflammation Research Centre, Research Institute of Internal Medicine, Oslo University Hospital, Rikshospitalet, Oslo, Norway,Institute of Clinical Medicine, University of Oslo, Oslo, Norway
| | - Corey Tan
- Norwegian PSC Research Center, Division of Cancer, Surgery and Transplantation, Oslo University Hospital, Rikshospitalet, Oslo, Norway,K.G. Jebsen Inflammation Research Centre, Research Institute of Internal Medicine, Oslo University Hospital, Rikshospitalet, Oslo, Norway
| | - Tom H. Karlsen
- Norwegian PSC Research Center, Division of Cancer, Surgery and Transplantation, Oslo University Hospital, Rikshospitalet, Oslo, Norway,K.G. Jebsen Inflammation Research Centre, Research Institute of Internal Medicine, Oslo University Hospital, Rikshospitalet, Oslo, Norway,Institute of Clinical Medicine, University of Oslo, Oslo, Norway
| | - Jon Sponheim
- K.G. Jebsen Inflammation Research Centre, Research Institute of Internal Medicine, Oslo University Hospital, Rikshospitalet, Oslo, Norway,Section of Gastroenterology, Department of Transplantation Medicine, Division of Cancer Medicine, Surgery and Transplantation, Oslo University Hospital, Rikshospitalet, Oslo, Norway,Laboratory of Immunohistochemistry and Immunopathology, Department of Pathology, Oslo University Hospital, Rikshospitalet, Oslo, Norway
| | - Niklas K. Björkström
- Center for Infectious Medicine, Department of Medicine, Karolinska Institutet, Stockholm, Sweden,Liver Immunology Laboratory, Department of Medicine, Karolinska Institutet, Stockholm, Sweden
| | - Olav Sundnes
- Laboratory of Immunohistochemistry and Immunopathology, Department of Pathology, Oslo University Hospital, Rikshospitalet, Oslo, Norway,K.G. Jebsen Inflammation Research Centre, Oslo University Hospital, Rikshospitalet, Oslo, Norway
| | - Kristian Alfsnes
- Norwegian PSC Research Center, Division of Cancer, Surgery and Transplantation, Oslo University Hospital, Rikshospitalet, Oslo, Norway,K.G. Jebsen Inflammation Research Centre, Research Institute of Internal Medicine, Oslo University Hospital, Rikshospitalet, Oslo, Norway
| | - Arthur Kaser
- Department of Medicine, Addenbrooke's Hospital, University of Cambridge, Cambridge, UK
| | - Douglas M. Jefferson
- Department of Integrative Physiology and Pathobiology, Sackler School, Tufts University School of Medicine, Boston, MA, USA
| | - Yoshiyuki Ueno
- Division of Gastroenterology, Yamagata University Faculty of Medicine, Yamagata, Japan
| | - Tor J. Eide
- Institute of Clinical Medicine, University of Oslo, Oslo, Norway,Department of Pathology, Oslo University Hospital, Rikshospitalet, Oslo, Norway
| | - Guttorm Haraldsen
- Laboratory of Immunohistochemistry and Immunopathology, Department of Pathology, Oslo University Hospital, Rikshospitalet, Oslo, Norway,K.G. Jebsen Inflammation Research Centre, Oslo University Hospital, Rikshospitalet, Oslo, Norway
| | - Sebastian Zeissig
- Department of Internal Medicine, University Hospital Schleswig-Holstein, Kiel, Germany
| | - Mark A. Exley
- Manchester Collaborative Centre for Inflammation Research (MCCIR), Faculty of Medical & Human Sciences, University of Manchester, Manchester, UK,Division of Gastroenterology, Hepatology and Endoscopy, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA
| | - Richard S. Blumberg
- Division of Gastroenterology, Hepatology and Endoscopy, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA
| | - Espen Melum
- Norwegian PSC Research Center, Division of Cancer, Surgery and Transplantation, Oslo University Hospital, Rikshospitalet, Oslo, Norway,K.G. Jebsen Inflammation Research Centre, Research Institute of Internal Medicine, Oslo University Hospital, Rikshospitalet, Oslo, Norway
| |
Collapse
|
5
|
Pollheimer J, Bodin J, Sundnes O, Edelmann RJ, Skånland SS, Sponheim J, Brox MJ, Sundlisæter E, Loos T, Vatn M, Kasprzycka M, Wang J, Küchler AM, Taskén K, Haraldsen G, Hol J. Interleukin-33 Drives a Proinflammatory Endothelial Activation That Selectively Targets Nonquiescent Cells. Arterioscler Thromb Vasc Biol 2013; 33:e47-55. [DOI: 10.1161/atvbaha.112.253427] [Citation(s) in RCA: 40] [Impact Index Per Article: 3.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/15/2022]
Affiliation(s)
- Jürgen Pollheimer
- From the LIIPAT, Institute of Pathology, University of Oslo, Oslo, Norway (J.P., O.S., R.J.E., J.S., M.J.B., E.S., T.L., M.K., A.M.K., G.H., J.H.); Department of Pathology, Oslo University Hospital, Oslo, Norway (J.P., J.B., O.S., R.J.E., E.S., T.L., M.K., J.W., A.M.K., G.H., J.H.); Department of Obstetrics and Fetal-Maternal Medicine, Medical University of Vienna, Austria (J.P.); Division of Environmental Medicine, Norwegian Institute of Public Health, Oslo, Norway (J.B.); Centre for Molecular
| | - Johanna Bodin
- From the LIIPAT, Institute of Pathology, University of Oslo, Oslo, Norway (J.P., O.S., R.J.E., J.S., M.J.B., E.S., T.L., M.K., A.M.K., G.H., J.H.); Department of Pathology, Oslo University Hospital, Oslo, Norway (J.P., J.B., O.S., R.J.E., E.S., T.L., M.K., J.W., A.M.K., G.H., J.H.); Department of Obstetrics and Fetal-Maternal Medicine, Medical University of Vienna, Austria (J.P.); Division of Environmental Medicine, Norwegian Institute of Public Health, Oslo, Norway (J.B.); Centre for Molecular
| | - Olav Sundnes
- From the LIIPAT, Institute of Pathology, University of Oslo, Oslo, Norway (J.P., O.S., R.J.E., J.S., M.J.B., E.S., T.L., M.K., A.M.K., G.H., J.H.); Department of Pathology, Oslo University Hospital, Oslo, Norway (J.P., J.B., O.S., R.J.E., E.S., T.L., M.K., J.W., A.M.K., G.H., J.H.); Department of Obstetrics and Fetal-Maternal Medicine, Medical University of Vienna, Austria (J.P.); Division of Environmental Medicine, Norwegian Institute of Public Health, Oslo, Norway (J.B.); Centre for Molecular
| | - Reidunn J. Edelmann
- From the LIIPAT, Institute of Pathology, University of Oslo, Oslo, Norway (J.P., O.S., R.J.E., J.S., M.J.B., E.S., T.L., M.K., A.M.K., G.H., J.H.); Department of Pathology, Oslo University Hospital, Oslo, Norway (J.P., J.B., O.S., R.J.E., E.S., T.L., M.K., J.W., A.M.K., G.H., J.H.); Department of Obstetrics and Fetal-Maternal Medicine, Medical University of Vienna, Austria (J.P.); Division of Environmental Medicine, Norwegian Institute of Public Health, Oslo, Norway (J.B.); Centre for Molecular
| | - Sigrid S. Skånland
- From the LIIPAT, Institute of Pathology, University of Oslo, Oslo, Norway (J.P., O.S., R.J.E., J.S., M.J.B., E.S., T.L., M.K., A.M.K., G.H., J.H.); Department of Pathology, Oslo University Hospital, Oslo, Norway (J.P., J.B., O.S., R.J.E., E.S., T.L., M.K., J.W., A.M.K., G.H., J.H.); Department of Obstetrics and Fetal-Maternal Medicine, Medical University of Vienna, Austria (J.P.); Division of Environmental Medicine, Norwegian Institute of Public Health, Oslo, Norway (J.B.); Centre for Molecular
| | - Jon Sponheim
- From the LIIPAT, Institute of Pathology, University of Oslo, Oslo, Norway (J.P., O.S., R.J.E., J.S., M.J.B., E.S., T.L., M.K., A.M.K., G.H., J.H.); Department of Pathology, Oslo University Hospital, Oslo, Norway (J.P., J.B., O.S., R.J.E., E.S., T.L., M.K., J.W., A.M.K., G.H., J.H.); Department of Obstetrics and Fetal-Maternal Medicine, Medical University of Vienna, Austria (J.P.); Division of Environmental Medicine, Norwegian Institute of Public Health, Oslo, Norway (J.B.); Centre for Molecular
| | - Mari Johanna Brox
- From the LIIPAT, Institute of Pathology, University of Oslo, Oslo, Norway (J.P., O.S., R.J.E., J.S., M.J.B., E.S., T.L., M.K., A.M.K., G.H., J.H.); Department of Pathology, Oslo University Hospital, Oslo, Norway (J.P., J.B., O.S., R.J.E., E.S., T.L., M.K., J.W., A.M.K., G.H., J.H.); Department of Obstetrics and Fetal-Maternal Medicine, Medical University of Vienna, Austria (J.P.); Division of Environmental Medicine, Norwegian Institute of Public Health, Oslo, Norway (J.B.); Centre for Molecular
| | - Eirik Sundlisæter
- From the LIIPAT, Institute of Pathology, University of Oslo, Oslo, Norway (J.P., O.S., R.J.E., J.S., M.J.B., E.S., T.L., M.K., A.M.K., G.H., J.H.); Department of Pathology, Oslo University Hospital, Oslo, Norway (J.P., J.B., O.S., R.J.E., E.S., T.L., M.K., J.W., A.M.K., G.H., J.H.); Department of Obstetrics and Fetal-Maternal Medicine, Medical University of Vienna, Austria (J.P.); Division of Environmental Medicine, Norwegian Institute of Public Health, Oslo, Norway (J.B.); Centre for Molecular
| | - Tamara Loos
- From the LIIPAT, Institute of Pathology, University of Oslo, Oslo, Norway (J.P., O.S., R.J.E., J.S., M.J.B., E.S., T.L., M.K., A.M.K., G.H., J.H.); Department of Pathology, Oslo University Hospital, Oslo, Norway (J.P., J.B., O.S., R.J.E., E.S., T.L., M.K., J.W., A.M.K., G.H., J.H.); Department of Obstetrics and Fetal-Maternal Medicine, Medical University of Vienna, Austria (J.P.); Division of Environmental Medicine, Norwegian Institute of Public Health, Oslo, Norway (J.B.); Centre for Molecular
| | - Morten Vatn
- From the LIIPAT, Institute of Pathology, University of Oslo, Oslo, Norway (J.P., O.S., R.J.E., J.S., M.J.B., E.S., T.L., M.K., A.M.K., G.H., J.H.); Department of Pathology, Oslo University Hospital, Oslo, Norway (J.P., J.B., O.S., R.J.E., E.S., T.L., M.K., J.W., A.M.K., G.H., J.H.); Department of Obstetrics and Fetal-Maternal Medicine, Medical University of Vienna, Austria (J.P.); Division of Environmental Medicine, Norwegian Institute of Public Health, Oslo, Norway (J.B.); Centre for Molecular
| | - Monika Kasprzycka
- From the LIIPAT, Institute of Pathology, University of Oslo, Oslo, Norway (J.P., O.S., R.J.E., J.S., M.J.B., E.S., T.L., M.K., A.M.K., G.H., J.H.); Department of Pathology, Oslo University Hospital, Oslo, Norway (J.P., J.B., O.S., R.J.E., E.S., T.L., M.K., J.W., A.M.K., G.H., J.H.); Department of Obstetrics and Fetal-Maternal Medicine, Medical University of Vienna, Austria (J.P.); Division of Environmental Medicine, Norwegian Institute of Public Health, Oslo, Norway (J.B.); Centre for Molecular
| | - Junbai Wang
- From the LIIPAT, Institute of Pathology, University of Oslo, Oslo, Norway (J.P., O.S., R.J.E., J.S., M.J.B., E.S., T.L., M.K., A.M.K., G.H., J.H.); Department of Pathology, Oslo University Hospital, Oslo, Norway (J.P., J.B., O.S., R.J.E., E.S., T.L., M.K., J.W., A.M.K., G.H., J.H.); Department of Obstetrics and Fetal-Maternal Medicine, Medical University of Vienna, Austria (J.P.); Division of Environmental Medicine, Norwegian Institute of Public Health, Oslo, Norway (J.B.); Centre for Molecular
| | - Axel M. Küchler
- From the LIIPAT, Institute of Pathology, University of Oslo, Oslo, Norway (J.P., O.S., R.J.E., J.S., M.J.B., E.S., T.L., M.K., A.M.K., G.H., J.H.); Department of Pathology, Oslo University Hospital, Oslo, Norway (J.P., J.B., O.S., R.J.E., E.S., T.L., M.K., J.W., A.M.K., G.H., J.H.); Department of Obstetrics and Fetal-Maternal Medicine, Medical University of Vienna, Austria (J.P.); Division of Environmental Medicine, Norwegian Institute of Public Health, Oslo, Norway (J.B.); Centre for Molecular
| | - Kjetil Taskén
- From the LIIPAT, Institute of Pathology, University of Oslo, Oslo, Norway (J.P., O.S., R.J.E., J.S., M.J.B., E.S., T.L., M.K., A.M.K., G.H., J.H.); Department of Pathology, Oslo University Hospital, Oslo, Norway (J.P., J.B., O.S., R.J.E., E.S., T.L., M.K., J.W., A.M.K., G.H., J.H.); Department of Obstetrics and Fetal-Maternal Medicine, Medical University of Vienna, Austria (J.P.); Division of Environmental Medicine, Norwegian Institute of Public Health, Oslo, Norway (J.B.); Centre for Molecular
| | - Guttorm Haraldsen
- From the LIIPAT, Institute of Pathology, University of Oslo, Oslo, Norway (J.P., O.S., R.J.E., J.S., M.J.B., E.S., T.L., M.K., A.M.K., G.H., J.H.); Department of Pathology, Oslo University Hospital, Oslo, Norway (J.P., J.B., O.S., R.J.E., E.S., T.L., M.K., J.W., A.M.K., G.H., J.H.); Department of Obstetrics and Fetal-Maternal Medicine, Medical University of Vienna, Austria (J.P.); Division of Environmental Medicine, Norwegian Institute of Public Health, Oslo, Norway (J.B.); Centre for Molecular
| | - Johanna Hol
- From the LIIPAT, Institute of Pathology, University of Oslo, Oslo, Norway (J.P., O.S., R.J.E., J.S., M.J.B., E.S., T.L., M.K., A.M.K., G.H., J.H.); Department of Pathology, Oslo University Hospital, Oslo, Norway (J.P., J.B., O.S., R.J.E., E.S., T.L., M.K., J.W., A.M.K., G.H., J.H.); Department of Obstetrics and Fetal-Maternal Medicine, Medical University of Vienna, Austria (J.P.); Division of Environmental Medicine, Norwegian Institute of Public Health, Oslo, Norway (J.B.); Centre for Molecular
| |
Collapse
|